At Health Canada, we're responsible to make sure that before any drug is exported from here under the patent regime, it's safe, efficacious, and of high quality. So it's the same as a Canadian citizen would get; no double standard. Plus, we have to make sure that the markings for diversion are present so that the drug is sent over and is different from the brand-patented product here in Canada.
On April 16th, 2007. See this statement in context.